Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1204

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 4
Chunk 1204
---
 us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.

We
believe that these provisions and the insurance are necessary to attract and retain talented and experienced officers and directors.

ITEM
11. EXECUTIVE COMPENSATION

2024
Summary Compensation Table 

The
following summary compensation table provides information regarding the compensation earned during our fiscal years ended December 31,
2024 and 2023 to certain of our executive officers, who we collectively refer to as our “named executive officers” or “NEOs”.

    Name  and Principal Position 
    Year  
    Salary ($)  
    Bonus ($)  
    Stock Awards ($)  
    Option Awards ($)(1)  
    Non- Equity Incentive Plan Compensation ($)  
    Non- qualified Deferred Compensation Earnings ($)  
    All Other Compensation ($)  
    Total ($) 
  
    Christer Rosén 
    2024  
     134,750  
         -  
     -  
     -  
             -  
            -  
     19,326(2) 
    $154,076 
  
    Chief Executive Officer 
    2023(3) 
     -  
     -  
     661,531  
     771,550  
     -  
     -  
     4,286(4) 
     1,437,367 

    Saleem Elmasri 
    2024  
     127,006  
     -  
     -  
     -  
     -  
     -  
     -(5) 
     127,006 
  
    Chief Financial Officer 
    2023(6) 
     -  
     -  
     88,168  
     690,335  
     -  
     -  
     -(7) 
     778,503 

    Marshall Hayward 
    2024  
     107,800  
     -  
     -  
     -  
     -  
     -  
     -(8) 
     107,800 
  
    Chief Scientific Officer